Name: UMIN ID:
Unique ID issued by UMIN | UMIN000002529 |
---|---|
Receipt number | R000003089 |
Scientific Title | Targeted radiotherapy for malignant neuroendocrine tumors with I-131 metaiodobenzylguanidine (MIBG) |
Date of disclosure of the study information | 2009/09/18 |
Last modified on | 2019/05/20 14:57:13 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/09/18 16:08:56 | ||
2 | Update | 2015/04/20 08:22:00 | UMIN ID1 |
|
3 | Update | 2015/04/20 15:51:04 | Email Address Address TEL Name of person sending information Organization Division name Division name Address Post marketing survey by drug manufacture etc., specified by Japanese law. Organization1 |
|
4 | Update | 2016/09/23 15:50:06 | Name of primary person or sponsor Organization |
|
5 | Update | 2019/03/29 09:34:26 | Target sample size |
|
6 | Update | 2019/03/29 09:39:11 | Date of IRB Anticipated trial start date Last follow-up date |
|
7 | Update | 2019/04/24 17:45:39 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
8 | Update | 2019/05/20 14:57:13 | Recruitment status Other related information |